Evaluating the medical management of locally advanced and metastatic basal cell carcinoma: A single institutional retrospective analysis investigating efficacy, safety, and tolerability.

Belzer, Annika; Pach, Jolanta; Mortlock, Ryland D; Clune, James; Olino, Kelly; Sznol, Mario; Bhatia, Aarti; Burtness, Barbara; Christensen, Sean; Leventhal, Jonathan S

Belzer, Annika; Pach, Jolanta; Mortlock, Ryland D; Clune, James; Olino, Kelly; Sznol, Mario; Bhatia, Aarti; Burtness, Barbara; Christensen, Sean; Leventhal, Jonathan S.

Afiliação

Belzer A; Department of Dermatology, Yale School of Medicine, New Haven, Connecticut.
Pach J; Department of Dermatology, Yale School of Medicine, New Haven, Connecticut.
Mortlock RD; Department of Dermatology, Yale School of Medicine, New Haven, Connecticut.
Clune J; Department of Plastic Surgery, Yale School of Medicine, New Haven, Connecticut.
Olino K; Department of Surgical Oncology, Yale School of Medicine, New Haven, Connecticut.
Sznol M; Department of Internal Medicine and Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut.
Bhatia A; Department of Internal Medicine and Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut.
Burtness B; Department of Internal Medicine and Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut.
Christensen S; Department of Dermatology, Yale School of Medicine, New Haven, Connecticut.
Leventhal JS; Department of Dermatology, Yale School of Medicine, New Haven, Connecticut.

JAAD Int ; 11: 174-175, 2023 Jun.

Article em En | MEDLINE | ID: mdl-37252181

Palavras-chave

HPI; ICI; aBCC; advanced basal cell carcinoma; basal cell carcinoma; checkpoint inhibitor; cutaneous oncology; hedgehog pathway inhibitor; immunotherapy

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: JAAD Int Ano de publicação: 2023 Tipo de documento: Article